Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: ADC THERAPEUTICS AMERICA, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-09-29 to 2027-12-29
Current total value of award: $194000
Description: STABILITY TESTING SERVICES AND DRUG MASTER FILE MAINTENANCE FOR ANTIBODY DRUG CONJUGATE ADCT-701